138 related articles for article (PubMed ID: 15867485)
1. Combination of anti-estrogenic therapy with radiation in breast cancer: simultaneous or sequential treatment?
Schmidberger H; Hermann RM; Hess CF; Emons G
Onkologie; 2005 May; 28(5):275-80. PubMed ID: 15867485
[TBL] [Abstract][Full Text] [Related]
2. Interactions between radiation and endocrine therapy in breast cancer.
Schmidberger H; Hermann RM; Hess CF; Emons G
Endocr Relat Cancer; 2003 Sep; 10(3):375-88. PubMed ID: 14503914
[TBL] [Abstract][Full Text] [Related]
3. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].
Hoeller U; Borgmann K; Feyer P; Souchon R;
Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
Cunnick GH; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials.
Petrelli F; Barni S
Radiother Oncol; 2011 Aug; 100(2):195-9. PubMed ID: 21411161
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
Sautter-Bihl ML
Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
[No Abstract] [Full Text] [Related]
7. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
Hird RB; Chang A; Cimmino V; Diehl K; Sabel M; Kleer C; Helvie M; Schott A; Young J; Hayes D; Newman L
Cancer; 2006 May; 106(10):2113-8. PubMed ID: 16596655
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.
Fisher B; Bryant J; Dignam JJ; Wickerham DL; Mamounas EP; Fisher ER; Margolese RG; Nesbitt L; Paik S; Pisansky TM; Wolmark N;
J Clin Oncol; 2002 Oct; 20(20):4141-9. PubMed ID: 12377957
[TBL] [Abstract][Full Text] [Related]
9. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
10. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
11. Current controversies in the treatment of ductal carcinoma in situ of the breast.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
[TBL] [Abstract][Full Text] [Related]
12. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM
Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
[TBL] [Abstract][Full Text] [Related]
14. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
[TBL] [Abstract][Full Text] [Related]
15. [Controversies in breast conservation treatment for breast cancer].
Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
18. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.
Singletary SE; Atkinson EN; Hoque A; Sneige N; Sahin AA; Fritsche HA; Lotan R; Lu T; Hittelman WN; Bevers TB; Stelling CB; Lippman SM
Clin Cancer Res; 2002 Sep; 8(9):2835-42. PubMed ID: 12231524
[TBL] [Abstract][Full Text] [Related]
20. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
